Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report
Primary squamous cell carcinoma of the breast is a rare subtype of carcinoma of chemosis for which there is no effective chemotherapy regimen. Breast squamous cell carcinoma is usually “triple negative”, with poor chemotherapy effects and poor prognosis. Here, we report a successful case of primary...
Main Authors: | Fangfang Gao, Jingtai Li, Haoran Liao, Pingming Fan, Minjian Wang, Yu Liu, Linwei Ding, Guankui Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1115422/full |
Similar Items
-
Acute thrombocytopenia induced by trastuzumab due to complement reaction: A case report
by: Guoping Chen, et al.
Published: (2022-12-01) -
Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report
by: He Jian, et al.
Published: (2021-11-01) -
The Effect of Whole-Grain Diet on the Gut Microbiota of the Elderly Individuals
by: Zeying Cui, et al.
Published: (2022-06-01) -
Investigation of lipid-rich carcinoma of the breast
by: Gao Fangfang, Du Guankui, Wang Minjian, Fan Pingming
Published: (2024-01-01) -
Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
by: Hong-Hong Zhang, et al.
Published: (2022-08-01)